CardioGenomic Testing Alliance

The CardioGenomic Testing Alliance (CGTA) is a collaborative alliance comprised of leading genomics companies and laboratories. The alliance was launched in March 2022 with the primary goal of educating heath care providers about the value of genomic testing in cardiology. Despite evolving technology and scientific guidelines from leading cardiology professional societies, utilization and awareness of genomic testing remains low among cardiovascular practitioners. This alliance seeks to unite genomics companies, laboratories, digital health companies, advocacy groups, and key leaders in cardiology to improve clinical outcomes through education and awareness of genomic testing in cardiology.